OSCR News & Analysis
4 articles
Market Mood
Oscar Health Inc (OSCR) Form 4 Filing Reported June 30
Oscar Health Inc (OSCR) submitted a Form 4 filing on June 30 indicating insider transactions involving company executives or directors. Such filings typically disclose the buying or selling of shares, which can impact investor sentiment and market perception. The transparency of these transactions is crucial for potential investors considering the company's stock. Although specific numbers regarding transactions were not provided, monitoring these filings is essential for understanding stock movements and insider confidence.
Read More: Oscar Health Inc (OSCR) Form 4 Filing Reported June 30
Oscar Health (OSCR) Director Mario Schlosser Sells $30.18M in Stock
Mario Schlosser, a director at Oscar Health (OSCR), sold $30.18 million worth of stock, according to regulatory filings. This transaction could indicate a shift in insider confidence, which may impact investor sentiment. The size of the sale raises questions about his outlook on the company's future performance. Such significant sales by insiders can often lead to increased scrutiny from investors regarding a company's financial health.
Read More: Oscar Health (OSCR) Director Mario Schlosser Sells $30.18M in Stock
Oscar Health (OSCR) Options Trading Reaches 52,384 Contracts
Oscar Health (OSCR) reported a significant increase in options trading, reaching a total of 52,384 contracts. This uptick in volume indicates heightened interest among investors, potentially reflecting changes in market sentiment towards the company's stock. Monitoring trading volumes can provide insights into future price movements. The surge in options trading could impact the stock's volatility and overall market perception of Oscar Health.
Read More: Oscar Health (OSCR) Options Trading Reaches 52,384 Contracts
Voya Financial (VOYA) Target Price Cut Amid RSI Warning Signals
As of May 1, 2026, Voya Financial (VOYA) was rated Underperform by B of A Securities with a price target lowered from $72 to $70. The stock gained approximately 20% over the past month, reaching a 52-week high of $83.55, with an RSI value of 77.9. Oscar Health (OSCR) experienced a 61% increase in its stock price within the same timeframe, achieving a 52-week high of $23.80 and an RSI of 79. The significant RSI values for both companies indicate potential overbought conditions, which may concern investors focused on momentum trading.
Read More: Voya Financial (VOYA) Target Price Cut Amid RSI Warning Signals